TEVA revenue breakdown overview

TEVA revenue for the last year amounted to 59.51 B ILS, the most of which — 61.24 B ILS — came from its highest performing source at the moment, Generics, Innovative Medicines and Biopharmaceuticals, the year earlier bringing 58.44 B ILS. The greatest contribution to the revenue figure was made by United States — last year it brought TEVA 29.74 B ILS, and the year before that — 29.96 B ILS.